FWIW:
Aside from being one of the most contemptible "executives" in the history of Corporate America (those stories would fill a library).
At the top of the list, of course, is the entire VIOXX scandal ("crime" would be a more apt descriptor)… which, of course, was Kenny's baby.
:
But just on the $$$$ side:
When Frazier took over as CEO of Merck - Jan 1, 2011 - the share price of MRK was $36 and change.
Today, the share price of Merck is $73 and change.
For those who are bad at math:
That is an annualized return of 9% per year (just about to the penny)
That, even though Kenny had the advantage of taking over when the price of Merck was significantly depressed due to - in large part - the VIOXX scandal
.… and Kenny's handling of it
So - how was that performance by Kenny?
During that exact same time frame, the
S&P 500 rose from 1292 to 2905......
Which comes out to a 10.5% annualized return.
So, under Kenny, MRK didn't even match the S&P 500
Among its peer group?
At best, a mixed bag for Kenny... Eli Lilly, for one, has blown past Merck like they were standing still. Johnson and Johnson has been pretty similar, and Merck slightly outperformed Pfizer.
Bottom Line?
Kenny "Beetlejuice" Frazier's tenure shows that even if you are led by the lowest-of-the-low, one of the most contemptible scumbags in the history of Corporate America.....
It still doesn't guarantee financial success